Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00380-025-02554-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Super effect or methodological flaw: questioning the glucagon-like peptide-1 receptor agonist cancer narrative. Reply to Maier GA, Rathmann W, Kuß O [letter].
Diabetologia
September 2025
School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
In Reply: Clipping of Intracranial Aneurysms by Neurosurgical Trainees Is Safe and Effective: Statewide Retrospective Review of 638 Consecutive Cases in Queensland, Australia.
Neurosurgery
July 2025
Department of Neurosurgery, Townsville University Hospital, Douglas, Queensland, Australia.
Reply to Comment on "Effect of Transcatheter Edge-to-Edge Repair on Left Ventricular Flow Features".
Cardiovasc Eng Technol
September 2025
Department of Structural Heart Disease, National Center for Cardiovascular Disease, China and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".
Mol Psychiatry
September 2025
Hadassah BrainLabs Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Study on Age-specific Population at Risk of Developing Dementia, Anxiety and Depression Following Exposure to COVID-19.
Ann Neurosci
August 2025
School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, Uttarakhand, India.
Background: Memory, learning, language and decision-making are just some of the cognitive abilities that may be negatively impacted by neurological illnesses such as dementia, anxiety and depression.
Purpose: This research aims to examine the influence of demographic variables on the prevalence of dementia, anxiety and depression in patients recovering from COVID-19.
Methods: This research looks at those who are at risk of developing dementia, anxiety or depression after being exposed to COVID-19.